Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 19, 2025, 10:32 UTC
  • 0
  • 0 comments

What Is Microsoft Word: A Guide to the Leading Word Processing Software

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 19, 2025, 10:31 UTC
  • 0
  • 0 comments

Latest About Apple Watch Blood Oxygen Features

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 19, 2025, 10:21 UTC
  • 0
  • 0 comments

AMD Ryzen 7 2700X Review in 2026

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 19, 2025, 10:08 UTC
  • 0
  • 0 comments

Best Ultrawide Monitors (2026)

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 19, 2025, 10:03 UTC
  • 0
  • 0 comments

What Is Touch Typing: Mastering the Skill for Faster, Error-Free Typing

Market reaction Comment Full text

TEVA (TEVA)

  • Business News
  • Dec. 19, 2025, 08:30 UTC
  • 0
  • 0 comments

Teva Pharmaceutical Industries Ltd. - Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

Market reaction Comment Full text

Alvotech (ALVOW)

  • Business News
  • Dec. 19, 2025, 08:30 UTC
  • 0
  • 0 comments

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

Market reaction Comment Full text

Alvotech (ALVO)

  • Business News
  • Dec. 19, 2025, 08:30 UTC
  • 0
  • 0 comments

Alvotech og Teva ná samningi um að sala AVT06 hliðstæðunnar við Eylea má hefjast í Bandaríkjunum á fjórða ársfjórðungi 2026

Market reaction Comment Full text

Alvotech (ALVO)

  • Business News
  • Dec. 19, 2025, 08:30 UTC
  • 0
  • 0 comments

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

Market reaction Comment Full text

Teva Pharmaceutical Industries Limited (TEVA)

  • Business News
  • Dec. 19, 2025, 08:30 UTC
  • 0
  • 0 comments

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

Market reaction Comment Full text
  • Previous
  • 1
  • 2
  • 3
  • 4
  • Next

Search

News categories

  • Technical Exchange News(10587)
  • Event(1968)
  • SEC News(183994)
  • FDA Approval(9827)
  • Company Report(721)
  • Business News(122053)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin